Home/Pipeline/Acne & Skin Irritation Program

Acne & Skin Irritation Program

Acne, Eczema

CommercialMarketed

Key Facts

Indication
Acne, Eczema
Phase
Commercial
Status
Marketed
Company

About Sonoma Pharmaceuticals

Sonoma Pharmaceuticals' mission is to commercialize its proprietary, stable hypochlorous acid technology as a safe and effective alternative to traditional antimicrobials and disinfectants. The company has achieved significant commercial traction, with its products approved and sold in over 50 countries, and has built a diversified portfolio spanning prescription wound care, OTC dermatology, and veterinary health. Its strategy focuses on expanding its commercial partnerships, growing its direct OTC e-commerce business, and pursuing new regulatory approvals to leverage its versatile platform across multiple high-value markets.

View full company profile